The interest in SSc has also been motivated by the possible role of TNF-α in potentiating the PAF (platelet activating factor)-induced vasoconstriction in the pulmonary circulation, since ischemia and reperfusion are major determinants of lung endothelial injury [24,25,26]. This evidence concerns the gene TNF and systemic sclerosis.